78 related articles for article (PubMed ID: 21362794)
1. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis.
Guo MM; Yang KD; Yu HR; Kuo HC
J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794
[No Abstract] [Full Text] [Related]
2. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
Bout-Tabaku S; Rivas-Chacon R; Restrepo R
J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
[No Abstract] [Full Text] [Related]
3. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
[No Abstract] [Full Text] [Related]
4. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
Lai JH
J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
[No Abstract] [Full Text] [Related]
5. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Schneider R
J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
[TBL] [Abstract][Full Text] [Related]
6. Etanercept and warts.
Adams DR; Zaenglein AL; Hershey MS
J Drugs Dermatol; 2004; 3(6):601. PubMed ID: 15624740
[No Abstract] [Full Text] [Related]
7. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
Tauber T; Daniel D; Barash J; Turetz J; Morad Y
Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
[No Abstract] [Full Text] [Related]
8. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.
Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
Scand J Rheumatol; 2011 Mar; 40(2):150-2. PubMed ID: 20868307
[No Abstract] [Full Text] [Related]
9. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
10. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
11. Etanercept therapy in children with juvenile rheumatoid arthritis.
Hung JJ; Huang JL
J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis.
Takei S; Groh D; Bernstein B; Shaham B; Gallagher K; Reiff A
J Rheumatol; 2001 Jul; 28(7):1677-80. PubMed ID: 11469478
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor blockers in rheumatoid arthritis.
Pisetsky DS
N Engl J Med; 2000 Mar; 342(11):810-1. PubMed ID: 10717018
[No Abstract] [Full Text] [Related]
14. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
Kakkassery V; Mergler S; Pleyer U
Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
[TBL] [Abstract][Full Text] [Related]
15. Etanercept-induced encephalopathy in a 7-year-old child.
Ekici B; Aydın K; Cantez S; Ergül Y; Tatlı B
Pediatr Neurol; 2011 Oct; 45(4):271-3. PubMed ID: 21907894
[TBL] [Abstract][Full Text] [Related]
16. [Etanercept].
Mühlhäuser U; Münzel F; Eschenhagen T
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
[No Abstract] [Full Text] [Related]
17. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
18. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
[TBL] [Abstract][Full Text] [Related]
19. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
Liang TC; Yang YH; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
[TBL] [Abstract][Full Text] [Related]
20. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.
Lovell DJ; Giannini EH; Reiff A; Cawkwell GD; Silverman ED; Nocton JJ; Stein LD; Gedalia A; Ilowite NT; Wallace CA; Whitmore J; Finck BK
N Engl J Med; 2000 Mar; 342(11):763-9. PubMed ID: 10717011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
